BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10229856)

  • 1. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
    Noben-Trauth N; Paul WE; Sacks DL
    J Immunol; 1999 May; 162(10):6132-40. PubMed ID: 10229856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.
    Mohrs M; Ledermann B; Köhler G; Dorfmüller A; Gessner A; Brombacher F
    J Immunol; 1999 Jun; 162(12):7302-8. PubMed ID: 10358179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
    Dent AL; Doherty TM; Paul WE; Sher A; Staudt LM
    J Immunol; 1999 Aug; 163(4):2098-103. PubMed ID: 10438949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
    Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
    J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early IL-4 production does not predict susceptibility to Leishmania major.
    Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
    Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
    Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P
    J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional plasticity of the LACK-reactive Vbeta4-Valpha8 CD4(+) T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB / c mice.
    Maillard I; Launois P; Himmelrich H; Acha-Orbea H; Diggelmann H; Locksley RM; Louis JA
    Eur J Immunol; 2001 Apr; 31(4):1288-96. PubMed ID: 11298356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
    Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
    J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
    Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
    J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
    Elso C; Kumar B; Smyth G; Foote S; Handman E
    Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.
    Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.
    Heinzel FP; Rerko RM; Ahmed F; Pearlman E
    J Immunol; 1995 Jul; 155(2):730-9. PubMed ID: 7608551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
    Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I
    J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.